Evidence map›Paper›PMID 23578215›Full record

ArticleBMC infectious diseases2013

Accuracy of IgM antibody testing, FQ-PCR and culture in laboratory diagnosis of acute infection by Mycoplasma pneumoniae in adults and adolescents with community-acquired pneumonia.

Jiuxin Qu, Li Gu, Jiang Wu, Jianping Dong, Zenghui Pu, Yan Gao, Ming Hu, Yongxiang Zhang, Feng Gao, Bin Cao and 2 more

2 registry-linked trialsOpen access · goldAbstract readComparative Study
In one paragraph

Article in BMC infectious diseases, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
4.1field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02489578 unknown statusnot on this mapstarted 2015, after this paper: background citation

Management in Real-life of Patients Hospitalized With Community-acquired Pneumonia in China

TypeobservationalSponsorCapital Medical UniversityRan2015 to 2016Enrolled3,000ConditionsCommunity Acquired PneumoniaArmsother
NCT02492425 unknown statusnot on this mapstarted 2016, after this paper: background citation

Evaluating the Adherence to Guidelines' Empirical Antibiotic Recommendations and Outcome of Patients Admitted to a Hospital Ward With a Diagnosis of Community-acquired Pneumonia

TypeobservationalSponsorCapital Medical UniversityRan2016 to 2018Enrolled3,000ConditionsCommunity Acquired Pneumonia
3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 59 citations in OpenAlex.

  1. Reporting macrolide-resistantJournal of clinical microbiology · 2026
    Review
  2. Article
  3. Article
  4. Article
  5. Macrolide resistance inFrontiers in cellular and infection microbiology · 2025
    Article
  6. The investigation of P1 gene inNew microbes and new infections · 2022
    Article
  7. Observational
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Early Diagnosis ofFrontiers in pediatrics · 2019
    Article
  14. Article
  15. A study of community-acquiredColombia medica (Cali, Colombia) · 2018
    Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 9 institutions in 1 country.

Jiuxin Qu
Li Gu
Jiang Wu
Jianping Dong
Zenghui Pu
Yan Gao
Ming Hu
Yongxiang Zhang
Feng Gao
Bin Cao
Chen Wang
Beijing Network for Adult Community-Acquired Pneumonia (BNACAP)
Beijing Chao-Yang Hospital · CNBeijing Center for Disease Prevention and Control · CNBeijing Dao Pei Hospital · CNBeijing Haidian Hospital · CNBeijing Hospital · CNBeijing Luhe Hospital Affiliated to Capital Medical University · CNPeking University People's Hospital · CNWangjing Hospital of China Academy of Chinese Medical Sciences · CNYuhuangding Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundDiagnosis of community-acquired pneumonia (CAP) caused by Mycoplasma pneumoniae in adults and adolescents is hampered by a lack of rapid and standardized tests for detection.

methodsCAP patients from 12 teaching hospitals were prospectively and consecutively recruited. Basic and clinical information, throat swabs and paired sera were collected. Mycoplasma pneumoniae was detected by IgG and IgM antibody tests, fluorescence quantitative polymerase chain reaction (FQ-PCR) and culture. A comparative study of the diagnostic values of three methods, including sensitivity, specificity, positive and negative predictive values and positive likelihood ratio (PLR) was conducted. A fourfold or greater increase of IgG antibody titers of paired sera was set as the diagnostic "gold standard".

resultsOne hundred and twenty-five CAP patients (52.8% males, median age 47 years, range 14-85) were enrolled. Twenty-seven (21.6%) patients were diagnosed with acute Mycoplasma pneumoniae infections by the "gold standard". Specificity values of all three methods were around 90%. An increasing trend of sensitivity, positive predictive value and PLR was found, with the lowest in IgM testing (7.4%, 28.6% and 1.45), intermediate in FQ-PCR (40.7%, 50% and 3.63), and highest in culture (55.6%, 75% and 10.9).

conclusionsIn the defined group of patients, there was a good agreement between positive rate of MP cultivation of throat swabs and acute M. pneumoniae infection (PLR of 10.9). Since the sensitivity is low in all of the evaluated methods, the logical approach would be to incorporate PCR, culture and serological tests for optimum diagnosis of acute Mycoplasma pneumoniae infections in adults and adolescents.

Indexed as

Acute DiseaseAdolescentAdultAgedAged, 80 and overAntibodies, BacterialCommunity-Acquired InfectionsFemaleHumansImmunoglobulin GImmunoglobulin MMaleMiddle AgedMycoplasma pneumoniaePneumonia, MycoplasmaPolymerase Chain ReactionAntibodies, BacterialImmunoglobulin GImmunoglobulin M

Identifiers

PMID23578215
PMCPMC3637260
OpenAlexW2131997340

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.